CTRI/2013/04/003585招募中3 期
evetiracetam in neonatal seizures -a randomised study
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Babies admitted to NICU with seizures and babies having seizures during NICU stay with
- •Gestational age >= 30 wks Birth weight >= 1.5 kg Clinical or electrographic seizures Parental consent obtained
排除标准
- •Babies with renal serum creatinine > 2.0
- •Birth at < 30 weeks gestation Parents refuse consent
研究者
相似试验
尚未招募
Unknown
To compare the safety, efficacy and outcome of using Phenobarbitone and Levetiracetam in neonatal convulsionsCTRI/2024/08/072048RNT MEDICAL COLLEGE
终止
1 期
Levetiracetam Treatment of Neonatal SeizuresNeonatal SeizuresNCT02550028Children's Hospital of Fudan University60
已完成
不适用
evetiracetam (Keppra®) in neonates: safety of intravenous levetiracetam for neonates with seizureseonatal seizuresNervous System DiseasesEpisodic and paroxysmal disordersISRCTN53371491Erasmus Medical Centre (The Netherlands)10
已完成
2 期
evetiracetam (Keppra®) in neonatesNL-OMON30449Erasmus MC, Universitair Medisch Centrum Rotterdam10
进行中（未招募）
不适用
evetiracetam (Keppra®) in neonatesepileptic seizures in neonates admitted to the intensive care unitMedDRA version: 9.1Level: LLTClassification code 10041350Term: Somnolence neonatalMedDRA version: 9.1Level: LLTClassification code 10013573Term: DizzinessMedDRA version: 9.1Level: LLTClassification code 10004210Term: Behavioural disorderEUCTR2006-006804-12-NLErasmusMedical Center-Sophia